Mammografia (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mammografia" in Polish language version.

refsWebsite
Global rank Polish rank
2nd place
6th place
4th place
7th place
1st place
1st place
5th place
2nd place
87th place
5th place
3rd place
27th place
447th place
1,118th place
68th place
31st place
1,476th place
2,256th place
7th place
29th place
low place
low place
low place
4,294th place
low place
low place
8,738th place
165th place
3,680th place
6,345th place
low place
8,813th place
low place
low place
749th place
10th place
7,114th place
156th place
26th place
172nd place
4,025th place
low place
1,684th place
2,913th place

archive.is

asseco.pl

books.google.com

cancer.gov

cancer.org

doi.org

dx.doi.org

  • R.L. Egan, Experience with mammography in a tumor institution. Evaluation of 1,000 studies, „Radiology”, 75, 1960, s. 894–900, DOI10.1148/75.6.894, PMID13725888 [dostęp 2022-11-03] (ang.).
  • R.L. Clark i inni, Reproducibility of the technic of mammography (Egan) for cancer of the breast, „American Journal of Surgery”, 109, 1965, s. 127–133, DOI10.1016/s0002-9610(65)80133-7, PMID14261636 [dostęp 2022-11-03] (ang.).
  • S.J. El Yousef i inni, Initial experience with nuclear magnetic resonance (NMR) imaging of the human breast, „Journal of Computer Assisted Tomography”, 7 (2), 1983, s. 215–218, DOI10.1097/00004728-198304000-00001, PMID6300203 [dostęp 2022-11-03] (ang.).
  • Catherine G. Glynn i inni, Effect of transition to digital mammography on clinical outcomes, „Radiology”, 260 (3), 2011, s. 664–670, DOI10.1148/radiol.11110159, PMID21788529 [dostęp 2022-11-03] (ang.).
  • S.H. Woolf, R.S. Lawrence, Preserving scientific debate and patient choice: lessons from the Consensus Panel on Mammography Screening. National Institutes of Health, „Journal of the American Medical Association”, 278 (23), 1997, s. 2105–2108, DOI10.1001/jama.278.23.2105, PMID9403427 [dostęp 2022-11-03] (ang.).
  • Lisa M. Schwartz, Steven Woloshin, News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer, „Journal of the American Medical Association”, 287 (23), 2002, s. 3136–3142, DOI10.1001/jama.287.23.3136, PMID12069679 [dostęp 2022-11-03] (ang.).
  • Ole Olsen, Peter C. Gøtzsche, Screening for breast cancer with mammography, „Cochrane Database of Systematic Reviews”, 2001, DOI10.1002/14651858.cd001877 [dostęp 2022-11-03] (ang.).
  • P. Boyle, Global summit on mammographic screening, „Annals of Oncology”, 14 (8), 2003, s. 1159–1160, DOI10.1093/annonc/mdg318 [dostęp 2022-11-03] (ang.).
  • Peter C. Gøtzsche, Margrethe Nielsen, Screening for breast cancer with mammography, „Cochrane Database of Systematic Reviews”, 2006, DOI10.1002/14651858.cd001877.pub2 (ang.).
  • Peter C. Gøtzsche, Margrethe Nielsen, Screening for breast cancer with mammography, „Cochrane Database of Systematic Reviews”, 2009, DOI10.1002/14651858.cd001877.pub3 (ang.).
  • Peter C. Gøtzsche, Margrethe Nielsen, Screening for breast cancer with mammography, „Cochrane Database of Systematic Reviews”, 2011, DOI10.1002/14651858.cd001877.pub4 (ang.).
  • Peter C. Gøtzsche, Karsten Juhl Jørgensen, Screening for breast cancer with mammography, „Cochrane Database of Systematic Reviews”, 2013 (6), 2013, DOI10.1002/14651858.CD001877.pub5, PMID23737396, PMCIDPMC6464778 [dostęp 2022-11-03] (ang.).
  • Eric A. Berns i inni, Digital and screen-film mammography: comparison of image acquisition and interpretation times, „American Journal of Roentgenology”, 187 (1), 2006, s. 38–41, DOI10.2214/AJR.05.1397, PMID16794152 [dostęp 2022-11-03] (ang.).
  • John M. Lewin i inni, Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer, „AJR. American journal of roentgenology”, 179 (3), 2002, s. 671–677, DOI10.2214/ajr.179.3.1790671, PMID12185042 [dostęp 2022-11-03] (ang.).
  • Per Skaane, Kari Young, Arnulf Skjennald, Population-based mammography screening: comparison of screen-film and full-field digital mammography with soft-copy reading--Oslo I study, „Radiology”, 229 (3), 2003, s. 877–884, DOI10.1148/radiol.2293021171, PMID14576447 [dostęp 2022-11-03] (ang.).
  • Etta D. Pisano i inni, American College of Radiology Imaging Network digital mammographic imaging screening trial: objectives and methodology, „Radiology”, 236 (2), 2005, s. 404–412, DOI10.1148/radiol.2362050440, PMID15961755 [dostęp 2022-11-03] (ang.).
  • Etta D. Pisano i inni, Diagnostic performance of digital versus film mammography for breast-cancer screening, „The New England Journal of Medicine”, 353 (17), 2005, s. 1773–1783, DOI10.1056/NEJMoa052911, PMID16169887 [dostęp 2022-11-03] (ang.).
  • Per Skaane, Arnulf Skjennald, Screen-film mammography versus full-field digital mammography with soft-copy reading: randomized trial in a population-based screening program--the Oslo II Study, „Radiology”, 232 (1), 2004, s. 197–204, DOI10.1148/radiol.2321031624, PMID15155893 [dostęp 2022-11-03] (ang.).
  • Per Skaane, Solveig Hofvind, Arnulf Skjennald, Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study, „Radiology”, 244 (3), 2007, s. 708–717, DOI10.1148/radiol.2443061478, PMID17709826 [dostęp 2022-11-03] (ang.).
  • C. Annette DuBard i inni, Recommendation for and receipt of cancer screenings among medicaid recipients 50 years and older, „Archives of Internal Medicine”, 168 (18), 2008, s. 2014–2021, DOI10.1001/archinte.168.18.2014, PMID18852404 [dostęp 2022-11-03] (ang.).
  • Kevin C. Oeffinger, Breast Cancer Surveillance Practices Among Women Previously Treated With Chest Radiation for a Childhood Cancer, „Journal of the American Medical Association”, 301 (4), 2009, s. 404, DOI10.1001/jama.2008.1039, PMID19176442, PMCIDPMC2676434 [dostęp 2022-11-03] (ang.).
  • A.J. Maxwell i inni, The Royal College of Radiologists Breast Group breast imaging classification, „Clinical Radiology”, 64 (6), 2009, s. 624–627, DOI10.1016/j.crad.2009.01.010, PMID19414086 [dostęp 2022-11-03] (ang.).
  • B. Barreau i inni, Une étude exploratoire sur le vécu psychologique des femmes lors de la surveillance des anomalies mammographiques probablement bénignes : à propos de 50 cas, „Gynecologie, Obstetrique & Fertilite”, 31 (7-8), 2003, s. 629–638, DOI10.1016/s1297-9589(03)00175-9, PMID14563609 [dostęp 2022-11-03] (fr.).
  • P. Taylor i inni, Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography, „Health Technology Assessment (Winchester, England)”, 9 (6), 2005, iii, 1–58, DOI10.3310/hta9060, PMID15717938 [dostęp 2022-11-03] (ang.).
  • Matthew Gromet, Comparison of computer-aided detection to double reading of screening mammograms: review of 231,221 mammograms, „AJR. American journal of roentgenology”, 190 (4), 2008, s. 854–859, DOI10.2214/AJR.07.2812, PMID18356428 [dostęp 2022-11-03] (ang.).
  • Meredith Noble i inni, Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis, „Archives of Gynecology and Obstetrics”, 279 (6), 2009, s. 881–890, DOI10.1007/s00404-008-0841-y, PMID19023581 [dostęp 2022-11-03] (ang.).
  • Lydia E. Pace, Nancy L. Keating, A systematic assessment of benefits and risks to guide breast cancer screening decisions, „Journal of the American Medical Association”, 311 (13), 2014, s. 1327–1335, DOI10.1001/jama.2014.1398, PMID24691608 [dostęp 2022-11-03] (ang.).
  • Elena B. Elkin i inni, The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999, „Cancer”, 104 (6), 2005, s. 1149–1157, DOI10.1002/cncr.21285, PMID16088887 [dostęp 2022-11-03] (ang.).
  • Richard J. Barth i inni, Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy, „AJR. American journal of roentgenology”, 184 (1), 2005, s. 324–329, DOI10.2214/ajr.184.1.01840324, PMID15615996 [dostęp 2022-11-03] (ang.).
  • Ahmedin Jemal i inni, Cancer statistics, 2008, „CA: a cancer journal for clinicians”, 58 (2), 2008, s. 71–96, DOI10.3322/CA.2007.0010, PMID18287387 [dostęp 2022-11-03] (ang.).
  • P. Autier i inni, Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database, „British Medical Journal”, 341, 2010, c3620–c3620, DOI10.1136/bmj.c3620, PMID20702548, PMCIDPMC2920378 [dostęp 2022-11-03] (ang.).
  • L Tabár i inni, What is the optimum interval between mammographic screening examinations — An analysis based on the latest results of the Swedish two-county breast cancer screening trial, „British Journal of Cancer”, 55 (5), 1987, s. 547–551, DOI10.1038/bjc.1987.112, PMID3606947, PMCIDPMC2001715 [dostęp 2022-11-03] (ang.).
  • Laura Esserman, Yiwey Shieh, Ian Thompson, Rethinking screening for breast cancer and prostate cancer, „Journal of the American Medical Association”, 302 (15), 2009, s. 1685–1692, DOI10.1001/jama.2009.1498, PMID19843904 [dostęp 2022-11-03] (ang.).
  • Nancy Breen, Jane F. Gentleman, Jeannine S. Schiller, Update on mammography trends: Comparisons of rates in 2000, 2005, and 2008, „Cancer”, 117 (10), 2011, s. 2209–2218, DOI10.1002/cncr.25679, PMID21523735, PMCIDPMC3117095 [dostęp 2022-11-03] (ang.).
  • John T. Schousboe i inni, Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness, „Annals of Internal Medicine”, 155 (1), 2011, s. 10, DOI10.7326/0003-4819-155-1-201107050-00003, PMID21727289, PMCIDPMC3759993 [dostęp 2022-11-03] (ang.).
  • Patricia A. Carney i inni, Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography, „Annals of Internal Medicine”, 138 (3), 2003, s. 168–175, DOI10.7326/0003-4819-138-3-200302040-00008, PMID12558355 [dostęp 2022-11-03] (ang.).
  • J.G. Elmore i inni, Variability in radiologists' interpretations of mammograms, „The New England Journal of Medicine”, 331 (22), 1994, s. 1493–1499, DOI10.1056/NEJM199412013312206, PMID7969300 [dostęp 2022-11-03] (ang.).
  • C.A. Beam, P.M. Layde, D.C. Sullivan, Variability in the interpretation of screening mammograms by US radiologists. Findings from a national sample, „Archives of Internal Medicine”, 156 (2), 1996, s. 209–213, DOI10.1001/archinte.1996.00440020119016, PMID8546556 [dostęp 2022-11-03] (ang.).
  • Nehmat Houssami, Accuracy and Outcomes of Screening Mammography in Women With a Personal History of Early-Stage Breast Cancer, „Journal of the American Medical Association”, 305 (8), 2011, s. 790, DOI10.1001/jama.2011.188, PMID21343578, PMCIDPMC3799940 [dostęp 2022-11-03] (ang.).
  • S. Shapiro i inni, Ten- to fourteen-year effect of screening on breast cancer mortality, „Journal of the National Cancer Institute”, 69 (2), 1982, s. 349–355, DOI10.1093/jnci/69.2.349, PMID6955542 [dostęp 2022-11-03] (ang.).
  • I. Andersson i inni, Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial., „British Medical Journal”, 297 (6654), 1988, s. 943–948, DOI10.1136/bmj.297.6654.943, PMID3142562, PMCIDPMC1834636, JSTOR29701156 [dostęp 2022-11-03] (ang.).
  • I. Andersson, L. Janzon, Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program, „Journal of the National Cancer Institute. Monographs” (22), 1997, s. 63–67, DOI10.1093/jncimono/1997.22.63, PMID9709278 [dostęp 2022-11-03] (ang.).
  • L. Tabàr, A. Gad, Screening for breast cancer: the Swedish trial, „Radiology”, 138 (1), 1981, s. 219–222, DOI10.1148/radiology.138.1.7005939, PMID7005939 [dostęp 2022-11-03] (ang.).
  • L. Tabár i inni, The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up, „Radiologic Clinics of North America”, 38 (4), 2000, s. 625–651, DOI10.1016/s0033-8389(05)70191-3, PMID10943268 [dostęp 2022-11-03] (ang.)..
  • Anthony B. Miller, The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years, „Annals of Internal Medicine”, 137 (5, Part 1), 2002, s. 305-312, DOI10.7326/0003-4819-137-5_Part_1-200209030-00005, PMID12204013 [dostęp 2022-11-03] (ang.).
  • A.B. Miller, Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years, „Journal of the National Cancer Institute”, 92 (18), 2000, s. 1490–1499, DOI10.1093/jnci/92.18.1490, PMID10995804 [dostęp 2023-04-11] (ang.).
  • Jan Frisell i inni, Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial, „Breast Cancer Research and Treatment”, 45 (3), 1997, s. 263–270, DOI10.1023/A:1005872617944 [dostęp 2023-04-11] (ang.).
  • Nils Bjurstam i inni, The Gothenburg Breast Screening Trial: The Gothenburg Breast Screening Trial, „Cancer”, 97 (10), 2003, s. 2387–2396, DOI10.1002/cncr.11361 [dostęp 2023-04-11] (ang.).
  • Sue M. Moss i inni, Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial, „The Lancet”, 368 (9552), 2006, s. 2053–2060, DOI10.1016/S0140-6736(06)69834-6, PMID17161727 [dostęp 2023-04-11] (ang.).
  • Daniel B. Kopans, The Most Recent Breast Cancer Screening Controversy About Whether Mammographic Screening Benefits Women at Any Age: Nonsense and Nonscience, „American Journal of Roentgenology”, 180 (1), 2003, s. 21–26, DOI10.2214/ajr.180.1.1800021 [dostęp 2023-04-11] (ang.).
  • R.G. Blanks i inni, The effect of changing from one to two views at incident (subsequent) screens in the NHS breast screening programme in England: impact on cancer detection and recall rates, „Clinical Radiology”, 60 (6), 2005, s. 674–680, DOI10.1016/j.crad.2005.01.008, PMID16038694 [dostęp 2023-04-11] (ang.).
  • Valerie P. Jackson, Screening Mammography: Controversies and Headlines, „Radiology”, 225 (2), 2002, s. 323–326, DOI10.1148/radiol.2252020465, PMID12409561 [dostęp 2023-04-11] (ang.).
  • David H. Newman, Screening for Breast and Prostate Cancers: Moving Toward Transparency, „JNCI: Journal of the National Cancer Institute”, 102 (14), 2010, s. 1008–1011, DOI10.1093/jnci/djq190, PMID20498425 [dostęp 2023-04-11] (ang.).
  • V.L. Ernster i inni, Incidence of and treatment for ductal carcinoma in situ of the breast, „Journal of the American Medical Association”, 275 (12), 1996, s. 913–918, DOI10.1001/jama.1996.03530360023033, PMID8598618 [dostęp 2023-04-11] (ang.).
  • D.L. Page i inni, Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy, „Cancer”, 76 (7), 1995, s. 1197–1200, DOI10.1002/1097-0142(19951001)76:7<1197::aid-cncr2820760715>3.0.co;2-0, PMID8630897 [dostęp 2023-04-11] (ang.).
  • Alexandra Barratt i inni, Model of outcomes of screening mammography: information to support informed choices, „British Medical Journal”, 330 (7497), 2005, s. 936, DOI10.1136/bmj.38398.469479.8F, PMID15755755, PMCIDPMC556337 [dostęp 2023-04-11] (ang.).
  • P. C Gøtzsche, On the benefits and harms of screening for breast cancer, „International Journal of Epidemiology”, 33 (1), 2004, s. 56–64, DOI10.1093/ije/dyh014, PMID15075145 [dostęp 2023-04-11] (ang.).
  • K.J. Jørgensen, P.C. Gøtzsche, Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends, „British Medical Journal”, 339 (jul09 1), 2009, b2587–b2587, DOI10.1136/bmj.b2587, PMID19589821, PMCIDPMC2714679 [dostęp 2023-04-11] (ang.).
  • K.J. Jørgensen, P.C. Gøtzsche, Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study, „British Medical Journal”, 328 (7432), 2004, s. 148–0, DOI10.1136/bmj.328.7432.148, PMID14726344, PMCIDPMC314513 [dostęp 2023-04-11] (ang.).
  • Joann G. Elmore i inni, Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations, „The New England Journal of Medicine”, 338 (16), 1998, s. 1089–1096, DOI10.1056/NEJM199804163381601, PMID9545356 [dostęp 2023-04-11] (ang.).
  • Joann G. Elmore i inni, Comment on: J. G. Elmore, M. B. Barton, V. M. Moceri, S. Polk, P. J. Arena, S. W. Fletcher, „Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations”, „The New England Journal of Medicine”, 338 (16), 1998, s. 1089–1096, DOI10.1056/NEJM199804163381601, PMID9714620 [dostęp 2023-04-11] (ang.).
  • Noel T. Brewer, Talya Salz, Sarah E. Lillie, Systematic Review: The Long-Term Effects of False-Positive Mammograms, „Annals of Internal Medicine”, 146 (7), 2007, s. 502, DOI10.7326/0003-4819-146-7-200704030-00006, PMID17404352 [dostęp 2023-04-11] (ang.).
  • Katrina Armstrong i inni, Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians, „Annals of Internal Medicine”, 146 (7), 2007, s. 516, DOI10.7326/0003-4819-146-7-200704030-00008, PMID17404354 [dostęp 2023-04-11] (ang.).
  • Dawn Miller, Vicki Livingstone, G Peter Herbison, Interventions for relieving the pain and discomfort of screening mammography, „Cochrane Database of Systematic Reviews”, 2009 (1), 2008, art. nr CD002942, DOI10.1002/14651858.CD002942.pub2, PMID18254010, PMCIDPMC8989268 [dostęp 2023-04-11] (ang.).
  • John C. Bailar, Mammography: A Contrary View, „Annals of Internal Medicine”, 84 (1), 1976, s. 77, DOI10.7326/0003-4819-84-1-77, PMID1106292 [dostęp 2023-04-18] (ang.).
  • N.A. Janjan i inni, Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease, „Cancer”, 61 (2), 1988, s. 252–254, DOI10.1002/1097-0142(19880115)61:2<252::aid-cncr2820610209>3.0.co;2-g, PMID3334958 [dostęp 2023-04-18] (ang.).
  • Smita Bhatia i inni, Breast Cancer and Other Second Neoplasms after Childhood Hodgkin's Disease, „The New England Journal of Medicine”, 334 (12), 1996, s. 745–751, DOI10.1056/NEJM199603213341201 [dostęp 2023-04-18] (ang.).
  • F.A. Mettler i inni, Benefits versus risks from mammography: a critical reassessment, „Cancer”, 77 (5), 1996, s. 903–909, DOI10.1002/(SICI)1097-0142(19960301)77:5<903::AID-CNCR15>3.0.CO;2-7, PMID8608482 [dostęp 2023-04-18] (ang.).
  • S.A. Feig, R.E. Hendrick, Radiation risk from screening mammography of women aged 40-49 years, „Journal of the National Cancer Institute. Monographs” (22), 1997, s. 119–124, DOI10.1093/jncimono/1997.22.119, PMID9709287 [dostęp 2023-04-18] (ang.).
  • Martin J. Yaffe, James G. Mainprize, Risk of Radiation-induced Breast Cancer from Mammographic Screening, „Radiology”, 258 (1), 2011, s. 98–105, DOI10.1148/radiol.10100655 [dostęp 2023-04-18] (ang.).
  • R. Edward Hendrick, Radiation Doses and Cancer Risks from Breast Imaging Studies, „Radiology”, 257 (1), 2010, s. 246–253, DOI10.1148/radiol.10100570 [dostęp 2023-04-18].
  • A. Berrington de González, G. Reeves, Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits, „British Journal of Cancer”, 93 (5), 2005, s. 590–596, DOI10.1038/sj.bjc.6602683, PMID16136033, PMCIDPMC2361593 [dostęp 2023-04-18] (ang.).
  • Daniel B. Kopans, Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast carcinoma mortality, „Cancer”, 94 (2), 2002, s. 580–581, DOI10.1002/cncr.10220 [dostęp 2023-04-18] (ang.).
  • Stephen W. Duffy i inni, The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties: A collaborative evaluation, „Cancer”, 95 (3), 2002, s. 458–469, DOI10.1002/cncr.10765 [dostęp 2023-04-18] (ang.).
  • A.B. Miller i inni, Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial, „British Medical Journal”, 348, 2014, g366–g366, DOI10.1136/bmj.g366, PMID24519768, PMCIDPMC3921437 [dostęp 2023-04-18] (ang.).
  • Joann G. Elmore i inni, Efficacy of Breast Cancer Screening in the Community According to Risk Level, „JNCI: Journal of the National Cancer Institute”, 97 (14), 2005, s. 1035–1043, DOI10.1093/jnci/dji183, PMID16030301 [dostęp 2023-04-18] (ang.).
  • K.J. Jørgensen, P.-H. Zahl, P. C Gøtzsche, Breast cancer mortality in organised mammography screening in Denmark: comparative study, „British Medical Journal”, 340, 2010, c1241–c1241, DOI10.1136/bmj.c1241, PMID20332505, PMCIDPMC2844939 [dostęp 2023-04-18] (ang.).
  • Mette Kalager i inni, Effect of screening mammography on breast-cancer mortality in Norway, „The New England Journal of Medicine”, 363 (13), 2010, s. 1203–1210, DOI10.1056/NEJMoa1000727, PMID20860502 [dostęp 2023-04-18] (ang.).
  • Harold J. Burstein i inni, Ductal carcinoma in situ of the breast, „The New England Journal of Medicine”, 350 (14), 2004, s. 1430–1441, DOI10.1056/NEJMra031301, PMID15070793 [dostęp 2023-04-18] (ang.).
  • Béatrice Barreau i inni, Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations, „European Journal of Radiology”, 54 (1), 2005, s. 55–61, DOI10.1016/j.ejrad.2004.11.019, PMID15797293 [dostęp 2023-04-18] (ang.).
  • Melinda E. Sanders i inni, The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up, „Cancer”, 103 (12), 2005, s. 2481–2484, DOI10.1002/cncr.21069 [dostęp 2023-04-18] (ang.).
  • Ann Partridge i inni, Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study, „Journal of the National Cancer Institute”, 100 (4), 2008, s. 243–251, DOI10.1093/jnci/djn010, PMID18270338 [dostęp 2023-04-18] (ang.).
  • Robert A. Smith i inni, American Cancer Society guidelines for breast cancer screening: update 2003, „CA: a cancer journal for clinicians”, 53 (3), 2003, s. 141–169, DOI10.3322/canjclin.53.3.141, PMID12809408 [dostęp 2023-04-18] (ang.).
  • Carol H. Lee i inni, Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer, „Journal of the American College of Radiology: JACR”, 7 (1), 2010, s. 18–27, DOI10.1016/j.jacr.2009.09.022, PMID20129267 [dostęp 2023-04-18] (ang.).
  • ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 42, April 2003. Breast cancer screening, „Obstetrics and Gynecology”, 101 (4), 2003, s. 821–831, DOI10.1016/s0029-7844(03)00253-9, PMID12685457 [dostęp 2023-04-18] (ang.).
  • US Preventive Services Task Force, Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement, „Annals of Internal Medicine”, 151 (10), 2009, 716–726, W–236, DOI10.7326/0003-4819-151-10-200911170-00008, PMID19920272 [dostęp 2023-04-18] (ang.).
  • Collaborative Group on Hormonal Factors in Breast Cancer, Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease, „The Lancet”, 358 (9291), 2001, s. 1389–1399, DOI10.1016/S0140-6736(01)06524-2, PMID11705483 [dostęp 2023-04-18] (ang.).
  • K. Kerlikowske i inni, Positive predictive value of screening mammography by age and family history of breast cancer, „Journal of the American Medical Association”, 270 (20), 1993, s. 2444–2450, DOI10.1001/jama.1993.03510200050031, PMID8230621 [dostęp 2023-04-18] (ang.).
  • H.C. Sox, Screening mammography in women younger than 50 years of age, „Annals of Internal Medicine”, 122 (7), 1995, s. 550–552, DOI10.7326/0003-4819-122-7-199504010-00013, PMID7872593 [dostęp 2023-04-18] (ang.).
  • R. Boer i inni, In search of the best upper age limit for breast cancer screening, „European Journal of Cancer”, 31A (12), 1995, s. 2040–2043, DOI10.1016/0959-8049(95)00457-2, PMID8562162 [dostęp 2023-04-18] (ang.).
  • M.E. Costanza, Breast cancer screening in older women. Synopsis of a forum, „Cancer”, 69 (7 Suppl), 1992, s. 1925–1931, DOI10.1002/1097-0142(19920401)69:7+<1925::aid-cncr2820691709>3.0.co;2-u, PMID1544093 [dostęp 2023-04-18] (ang.).
  • K.A. Phillips, G. Glendon, J.A. Knight, Putting the risk of breast cancer in perspective, „The New England Journal of Medicine”, 340 (2), 1999, s. 141–144, DOI10.1056/NEJM199901143400211, PMID9887168 [dostęp 2023-04-18] (ang.).

euref.org

europa.eu

ec.europa.eu

europarl.europa.eu

fda.gov

gazetaprawna.pl

praca.gazetaprawna.pl

iarc.fr

www-dep.iarc.fr

  • World Health Organisation databank, poprzez witrynę: CANCERMondial. International Agency for Research on Cancer.

jstor.org

kobiety.net.pl

zdrowie.kobiety.net.pl

mp.pl

nfz.gov.pl

csm-swd.nfz.gov.pl

nih.gov

ncbi.nlm.nih.gov

  • R.L. Egan, Experience with mammography in a tumor institution. Evaluation of 1,000 studies, „Radiology”, 75, 1960, s. 894–900, DOI10.1148/75.6.894, PMID13725888 [dostęp 2022-11-03] (ang.).
  • R.L. Clark i inni, Reproducibility of the technic of mammography (Egan) for cancer of the breast, „American Journal of Surgery”, 109, 1965, s. 127–133, DOI10.1016/s0002-9610(65)80133-7, PMID14261636 [dostęp 2022-11-03] (ang.).
  • L. Tabár, P.B. Dean, Interventional radiologic procedures in the investigation of lesions of the breast, „Radiologic Clinics of North America”, 17 (3), 1979, s. 607–621, PMID531198 [dostęp 2022-11-03] (ang.).
  • L. Tabár i inni, The significance of mammography, galactography, and pneumocystography in detecting occult carcinomas of the breast, „Surgery, Gynecology & Obstetrics”, 137 (6), 1973, s. 965–970, PMID4357256 [dostęp 2022-11-03] (ang.).
  • S.J. El Yousef i inni, Initial experience with nuclear magnetic resonance (NMR) imaging of the human breast, „Journal of Computer Assisted Tomography”, 7 (2), 1983, s. 215–218, DOI10.1097/00004728-198304000-00001, PMID6300203 [dostęp 2022-11-03] (ang.).
  • Catherine G. Glynn i inni, Effect of transition to digital mammography on clinical outcomes, „Radiology”, 260 (3), 2011, s. 664–670, DOI10.1148/radiol.11110159, PMID21788529 [dostęp 2022-11-03] (ang.).
  • S.H. Woolf, R.S. Lawrence, Preserving scientific debate and patient choice: lessons from the Consensus Panel on Mammography Screening. National Institutes of Health, „Journal of the American Medical Association”, 278 (23), 1997, s. 2105–2108, DOI10.1001/jama.278.23.2105, PMID9403427 [dostęp 2022-11-03] (ang.).
  • Lisa M. Schwartz, Steven Woloshin, News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer, „Journal of the American Medical Association”, 287 (23), 2002, s. 3136–3142, DOI10.1001/jama.287.23.3136, PMID12069679 [dostęp 2022-11-03] (ang.).
  • Peter C. Gøtzsche, Karsten Juhl Jørgensen, Screening for breast cancer with mammography, „Cochrane Database of Systematic Reviews”, 2013 (6), 2013, DOI10.1002/14651858.CD001877.pub5, PMID23737396, PMCIDPMC6464778 [dostęp 2022-11-03] (ang.).
  • Eric A. Berns i inni, Digital and screen-film mammography: comparison of image acquisition and interpretation times, „American Journal of Roentgenology”, 187 (1), 2006, s. 38–41, DOI10.2214/AJR.05.1397, PMID16794152 [dostęp 2022-11-03] (ang.).
  • John M. Lewin i inni, Clinical comparison of full-field digital mammography and screen-film mammography for detection of breast cancer, „AJR. American journal of roentgenology”, 179 (3), 2002, s. 671–677, DOI10.2214/ajr.179.3.1790671, PMID12185042 [dostęp 2022-11-03] (ang.).
  • Per Skaane, Kari Young, Arnulf Skjennald, Population-based mammography screening: comparison of screen-film and full-field digital mammography with soft-copy reading--Oslo I study, „Radiology”, 229 (3), 2003, s. 877–884, DOI10.1148/radiol.2293021171, PMID14576447 [dostęp 2022-11-03] (ang.).
  • Etta D. Pisano i inni, American College of Radiology Imaging Network digital mammographic imaging screening trial: objectives and methodology, „Radiology”, 236 (2), 2005, s. 404–412, DOI10.1148/radiol.2362050440, PMID15961755 [dostęp 2022-11-03] (ang.).
  • Etta D. Pisano i inni, Diagnostic performance of digital versus film mammography for breast-cancer screening, „The New England Journal of Medicine”, 353 (17), 2005, s. 1773–1783, DOI10.1056/NEJMoa052911, PMID16169887 [dostęp 2022-11-03] (ang.).
  • Per Skaane, Arnulf Skjennald, Screen-film mammography versus full-field digital mammography with soft-copy reading: randomized trial in a population-based screening program--the Oslo II Study, „Radiology”, 232 (1), 2004, s. 197–204, DOI10.1148/radiol.2321031624, PMID15155893 [dostęp 2022-11-03] (ang.).
  • Per Skaane, Solveig Hofvind, Arnulf Skjennald, Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study, „Radiology”, 244 (3), 2007, s. 708–717, DOI10.1148/radiol.2443061478, PMID17709826 [dostęp 2022-11-03] (ang.).
  • C. Annette DuBard i inni, Recommendation for and receipt of cancer screenings among medicaid recipients 50 years and older, „Archives of Internal Medicine”, 168 (18), 2008, s. 2014–2021, DOI10.1001/archinte.168.18.2014, PMID18852404 [dostęp 2022-11-03] (ang.).
  • Kevin C. Oeffinger, Breast Cancer Surveillance Practices Among Women Previously Treated With Chest Radiation for a Childhood Cancer, „Journal of the American Medical Association”, 301 (4), 2009, s. 404, DOI10.1001/jama.2008.1039, PMID19176442, PMCIDPMC2676434 [dostęp 2022-11-03] (ang.).
  • A.J. Maxwell i inni, The Royal College of Radiologists Breast Group breast imaging classification, „Clinical Radiology”, 64 (6), 2009, s. 624–627, DOI10.1016/j.crad.2009.01.010, PMID19414086 [dostęp 2022-11-03] (ang.).
  • B. Barreau i inni, Une étude exploratoire sur le vécu psychologique des femmes lors de la surveillance des anomalies mammographiques probablement bénignes : à propos de 50 cas, „Gynecologie, Obstetrique & Fertilite”, 31 (7-8), 2003, s. 629–638, DOI10.1016/s1297-9589(03)00175-9, PMID14563609 [dostęp 2022-11-03] (fr.).
  • P. Taylor i inni, Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography, „Health Technology Assessment (Winchester, England)”, 9 (6), 2005, iii, 1–58, DOI10.3310/hta9060, PMID15717938 [dostęp 2022-11-03] (ang.).
  • Matthew Gromet, Comparison of computer-aided detection to double reading of screening mammograms: review of 231,221 mammograms, „AJR. American journal of roentgenology”, 190 (4), 2008, s. 854–859, DOI10.2214/AJR.07.2812, PMID18356428 [dostęp 2022-11-03] (ang.).
  • Meredith Noble i inni, Computer-aided detection mammography for breast cancer screening: systematic review and meta-analysis, „Archives of Gynecology and Obstetrics”, 279 (6), 2009, s. 881–890, DOI10.1007/s00404-008-0841-y, PMID19023581 [dostęp 2022-11-03] (ang.).
  • Lydia E. Pace, Nancy L. Keating, A systematic assessment of benefits and risks to guide breast cancer screening decisions, „Journal of the American Medical Association”, 311 (13), 2014, s. 1327–1335, DOI10.1001/jama.2014.1398, PMID24691608 [dostęp 2022-11-03] (ang.).
  • Elena B. Elkin i inni, The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999, „Cancer”, 104 (6), 2005, s. 1149–1157, DOI10.1002/cncr.21285, PMID16088887 [dostęp 2022-11-03] (ang.).
  • Richard J. Barth i inni, Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy, „AJR. American journal of roentgenology”, 184 (1), 2005, s. 324–329, DOI10.2214/ajr.184.1.01840324, PMID15615996 [dostęp 2022-11-03] (ang.).
  • Ahmedin Jemal i inni, Cancer statistics, 2008, „CA: a cancer journal for clinicians”, 58 (2), 2008, s. 71–96, DOI10.3322/CA.2007.0010, PMID18287387 [dostęp 2022-11-03] (ang.).
  • P. Autier i inni, Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database, „British Medical Journal”, 341, 2010, c3620–c3620, DOI10.1136/bmj.c3620, PMID20702548, PMCIDPMC2920378 [dostęp 2022-11-03] (ang.).
  • L Tabár i inni, What is the optimum interval between mammographic screening examinations — An analysis based on the latest results of the Swedish two-county breast cancer screening trial, „British Journal of Cancer”, 55 (5), 1987, s. 547–551, DOI10.1038/bjc.1987.112, PMID3606947, PMCIDPMC2001715 [dostęp 2022-11-03] (ang.).
  • Laura Esserman, Yiwey Shieh, Ian Thompson, Rethinking screening for breast cancer and prostate cancer, „Journal of the American Medical Association”, 302 (15), 2009, s. 1685–1692, DOI10.1001/jama.2009.1498, PMID19843904 [dostęp 2022-11-03] (ang.).
  • Nancy Breen, Jane F. Gentleman, Jeannine S. Schiller, Update on mammography trends: Comparisons of rates in 2000, 2005, and 2008, „Cancer”, 117 (10), 2011, s. 2209–2218, DOI10.1002/cncr.25679, PMID21523735, PMCIDPMC3117095 [dostęp 2022-11-03] (ang.).
  • John T. Schousboe i inni, Personalizing Mammography by Breast Density and Other Risk Factors for Breast Cancer: Analysis of Health Benefits and Cost-Effectiveness, „Annals of Internal Medicine”, 155 (1), 2011, s. 10, DOI10.7326/0003-4819-155-1-201107050-00003, PMID21727289, PMCIDPMC3759993 [dostęp 2022-11-03] (ang.).
  • Patricia A. Carney i inni, Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography, „Annals of Internal Medicine”, 138 (3), 2003, s. 168–175, DOI10.7326/0003-4819-138-3-200302040-00008, PMID12558355 [dostęp 2022-11-03] (ang.).
  • J.G. Elmore i inni, Variability in radiologists' interpretations of mammograms, „The New England Journal of Medicine”, 331 (22), 1994, s. 1493–1499, DOI10.1056/NEJM199412013312206, PMID7969300 [dostęp 2022-11-03] (ang.).
  • C.A. Beam, P.M. Layde, D.C. Sullivan, Variability in the interpretation of screening mammograms by US radiologists. Findings from a national sample, „Archives of Internal Medicine”, 156 (2), 1996, s. 209–213, DOI10.1001/archinte.1996.00440020119016, PMID8546556 [dostęp 2022-11-03] (ang.).
  • Nehmat Houssami, Accuracy and Outcomes of Screening Mammography in Women With a Personal History of Early-Stage Breast Cancer, „Journal of the American Medical Association”, 305 (8), 2011, s. 790, DOI10.1001/jama.2011.188, PMID21343578, PMCIDPMC3799940 [dostęp 2022-11-03] (ang.).
  • S. Shapiro i inni, Ten- to fourteen-year effect of screening on breast cancer mortality, „Journal of the National Cancer Institute”, 69 (2), 1982, s. 349–355, DOI10.1093/jnci/69.2.349, PMID6955542 [dostęp 2022-11-03] (ang.).
  • I. Andersson i inni, Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial., „British Medical Journal”, 297 (6654), 1988, s. 943–948, DOI10.1136/bmj.297.6654.943, PMID3142562, PMCIDPMC1834636, JSTOR29701156 [dostęp 2022-11-03] (ang.).
  • I. Andersson, L. Janzon, Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program, „Journal of the National Cancer Institute. Monographs” (22), 1997, s. 63–67, DOI10.1093/jncimono/1997.22.63, PMID9709278 [dostęp 2022-11-03] (ang.).
  • L. Tabàr, A. Gad, Screening for breast cancer: the Swedish trial, „Radiology”, 138 (1), 1981, s. 219–222, DOI10.1148/radiology.138.1.7005939, PMID7005939 [dostęp 2022-11-03] (ang.).
  • L. Tabár i inni, The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up, „Radiologic Clinics of North America”, 38 (4), 2000, s. 625–651, DOI10.1016/s0033-8389(05)70191-3, PMID10943268 [dostęp 2022-11-03] (ang.)..
  • 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer, „The Lancet”, 353 (9168), 1999, s. 1909–1914, PMID10371568 [dostęp 2022-11-03] (ang.).
  • Anthony B. Miller, The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years, „Annals of Internal Medicine”, 137 (5, Part 1), 2002, s. 305-312, DOI10.7326/0003-4819-137-5_Part_1-200209030-00005, PMID12204013 [dostęp 2022-11-03] (ang.).
  • A.B. Miller, Canadian National Breast Screening Study-2: 13-Year Results of a Randomized Trial in Women Aged 50-59 Years, „Journal of the National Cancer Institute”, 92 (18), 2000, s. 1490–1499, DOI10.1093/jnci/92.18.1490, PMID10995804 [dostęp 2023-04-11] (ang.).
  • Sue M. Moss i inni, Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial, „The Lancet”, 368 (9552), 2006, s. 2053–2060, DOI10.1016/S0140-6736(06)69834-6, PMID17161727 [dostęp 2023-04-11] (ang.).
  • J.C. Bailar, B. MacMahon, Randomization in the Canadian National Breast Screening Study: a review for evidence of subversion, „CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne”, 156 (2), 1997, s. 193–199, PMID9012720, PMCIDPMC1226907 [dostęp 2023-04-11] (ang.).
  • R.G. Blanks i inni, The effect of changing from one to two views at incident (subsequent) screens in the NHS breast screening programme in England: impact on cancer detection and recall rates, „Clinical Radiology”, 60 (6), 2005, s. 674–680, DOI10.1016/j.crad.2005.01.008, PMID16038694 [dostęp 2023-04-11] (ang.).
  • Valerie P. Jackson, Screening Mammography: Controversies and Headlines, „Radiology”, 225 (2), 2002, s. 323–326, DOI10.1148/radiol.2252020465, PMID12409561 [dostęp 2023-04-11] (ang.).
  • David H. Newman, Screening for Breast and Prostate Cancers: Moving Toward Transparency, „JNCI: Journal of the National Cancer Institute”, 102 (14), 2010, s. 1008–1011, DOI10.1093/jnci/djq190, PMID20498425 [dostęp 2023-04-11] (ang.).
  • V.L. Ernster i inni, Incidence of and treatment for ductal carcinoma in situ of the breast, „Journal of the American Medical Association”, 275 (12), 1996, s. 913–918, DOI10.1001/jama.1996.03530360023033, PMID8598618 [dostęp 2023-04-11] (ang.).
  • D.L. Page i inni, Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy, „Cancer”, 76 (7), 1995, s. 1197–1200, DOI10.1002/1097-0142(19951001)76:7<1197::aid-cncr2820760715>3.0.co;2-0, PMID8630897 [dostęp 2023-04-11] (ang.).
  • Alexandra Barratt i inni, Model of outcomes of screening mammography: information to support informed choices, „British Medical Journal”, 330 (7497), 2005, s. 936, DOI10.1136/bmj.38398.469479.8F, PMID15755755, PMCIDPMC556337 [dostęp 2023-04-11] (ang.).
  • P. C Gøtzsche, On the benefits and harms of screening for breast cancer, „International Journal of Epidemiology”, 33 (1), 2004, s. 56–64, DOI10.1093/ije/dyh014, PMID15075145 [dostęp 2023-04-11] (ang.).
  • K.J. Jørgensen, P.C. Gøtzsche, Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends, „British Medical Journal”, 339 (jul09 1), 2009, b2587–b2587, DOI10.1136/bmj.b2587, PMID19589821, PMCIDPMC2714679 [dostęp 2023-04-11] (ang.).
  • K.J. Jørgensen, P.C. Gøtzsche, Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study, „British Medical Journal”, 328 (7432), 2004, s. 148–0, DOI10.1136/bmj.328.7432.148, PMID14726344, PMCIDPMC314513 [dostęp 2023-04-11] (ang.).
  • Joann G. Elmore i inni, Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations, „The New England Journal of Medicine”, 338 (16), 1998, s. 1089–1096, DOI10.1056/NEJM199804163381601, PMID9545356 [dostęp 2023-04-11] (ang.).
  • Joann G. Elmore i inni, Comment on: J. G. Elmore, M. B. Barton, V. M. Moceri, S. Polk, P. J. Arena, S. W. Fletcher, „Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations”, „The New England Journal of Medicine”, 338 (16), 1998, s. 1089–1096, DOI10.1056/NEJM199804163381601, PMID9714620 [dostęp 2023-04-11] (ang.).
  • Noel T. Brewer, Talya Salz, Sarah E. Lillie, Systematic Review: The Long-Term Effects of False-Positive Mammograms, „Annals of Internal Medicine”, 146 (7), 2007, s. 502, DOI10.7326/0003-4819-146-7-200704030-00006, PMID17404352 [dostęp 2023-04-11] (ang.).
  • Katrina Armstrong i inni, Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians, „Annals of Internal Medicine”, 146 (7), 2007, s. 516, DOI10.7326/0003-4819-146-7-200704030-00008, PMID17404354 [dostęp 2023-04-11] (ang.).
  • Dawn Miller, Vicki Livingstone, G Peter Herbison, Interventions for relieving the pain and discomfort of screening mammography, „Cochrane Database of Systematic Reviews”, 2009 (1), 2008, art. nr CD002942, DOI10.1002/14651858.CD002942.pub2, PMID18254010, PMCIDPMC8989268 [dostęp 2023-04-11] (ang.).
  • John C. Bailar, Mammography: A Contrary View, „Annals of Internal Medicine”, 84 (1), 1976, s. 77, DOI10.7326/0003-4819-84-1-77, PMID1106292 [dostęp 2023-04-18] (ang.).
  • N.A. Janjan i inni, Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease, „Cancer”, 61 (2), 1988, s. 252–254, DOI10.1002/1097-0142(19880115)61:2<252::aid-cncr2820610209>3.0.co;2-g, PMID3334958 [dostęp 2023-04-18] (ang.).
  • F.A. Mettler i inni, Benefits versus risks from mammography: a critical reassessment, „Cancer”, 77 (5), 1996, s. 903–909, DOI10.1002/(SICI)1097-0142(19960301)77:5<903::AID-CNCR15>3.0.CO;2-7, PMID8608482 [dostęp 2023-04-18] (ang.).
  • S.A. Feig, R.E. Hendrick, Radiation risk from screening mammography of women aged 40-49 years, „Journal of the National Cancer Institute. Monographs” (22), 1997, s. 119–124, DOI10.1093/jncimono/1997.22.119, PMID9709287 [dostęp 2023-04-18] (ang.).
  • A. Berrington de González, G. Reeves, Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits, „British Journal of Cancer”, 93 (5), 2005, s. 590–596, DOI10.1038/sj.bjc.6602683, PMID16136033, PMCIDPMC2361593 [dostęp 2023-04-18] (ang.).
  • A.B. Miller i inni, Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial, „British Medical Journal”, 348, 2014, g366–g366, DOI10.1136/bmj.g366, PMID24519768, PMCIDPMC3921437 [dostęp 2023-04-18] (ang.).
  • Joann G. Elmore i inni, Efficacy of Breast Cancer Screening in the Community According to Risk Level, „JNCI: Journal of the National Cancer Institute”, 97 (14), 2005, s. 1035–1043, DOI10.1093/jnci/dji183, PMID16030301 [dostęp 2023-04-18] (ang.).
  • K.J. Jørgensen, P.-H. Zahl, P. C Gøtzsche, Breast cancer mortality in organised mammography screening in Denmark: comparative study, „British Medical Journal”, 340, 2010, c1241–c1241, DOI10.1136/bmj.c1241, PMID20332505, PMCIDPMC2844939 [dostęp 2023-04-18] (ang.).
  • Mette Kalager i inni, Effect of screening mammography on breast-cancer mortality in Norway, „The New England Journal of Medicine”, 363 (13), 2010, s. 1203–1210, DOI10.1056/NEJMoa1000727, PMID20860502 [dostęp 2023-04-18] (ang.).
  • Harold J. Burstein i inni, Ductal carcinoma in situ of the breast, „The New England Journal of Medicine”, 350 (14), 2004, s. 1430–1441, DOI10.1056/NEJMra031301, PMID15070793 [dostęp 2023-04-18] (ang.).
  • Béatrice Barreau i inni, Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations, „European Journal of Radiology”, 54 (1), 2005, s. 55–61, DOI10.1016/j.ejrad.2004.11.019, PMID15797293 [dostęp 2023-04-18] (ang.).
  • Ann Partridge i inni, Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study, „Journal of the National Cancer Institute”, 100 (4), 2008, s. 243–251, DOI10.1093/jnci/djn010, PMID18270338 [dostęp 2023-04-18] (ang.).
  • Robert A. Smith i inni, American Cancer Society guidelines for breast cancer screening: update 2003, „CA: a cancer journal for clinicians”, 53 (3), 2003, s. 141–169, DOI10.3322/canjclin.53.3.141, PMID12809408 [dostęp 2023-04-18] (ang.).
  • Carol H. Lee i inni, Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer, „Journal of the American College of Radiology: JACR”, 7 (1), 2010, s. 18–27, DOI10.1016/j.jacr.2009.09.022, PMID20129267 [dostęp 2023-04-18] (ang.).
  • ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 42, April 2003. Breast cancer screening, „Obstetrics and Gynecology”, 101 (4), 2003, s. 821–831, DOI10.1016/s0029-7844(03)00253-9, PMID12685457 [dostęp 2023-04-18] (ang.).
  • US Preventive Services Task Force, Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement, „Annals of Internal Medicine”, 151 (10), 2009, 716–726, W–236, DOI10.7326/0003-4819-151-10-200911170-00008, PMID19920272 [dostęp 2023-04-18] (ang.).
  • Collaborative Group on Hormonal Factors in Breast Cancer, Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease, „The Lancet”, 358 (9291), 2001, s. 1389–1399, DOI10.1016/S0140-6736(01)06524-2, PMID11705483 [dostęp 2023-04-18] (ang.).
  • K. Kerlikowske i inni, Positive predictive value of screening mammography by age and family history of breast cancer, „Journal of the American Medical Association”, 270 (20), 1993, s. 2444–2450, DOI10.1001/jama.1993.03510200050031, PMID8230621 [dostęp 2023-04-18] (ang.).
  • H.C. Sox, Screening mammography in women younger than 50 years of age, „Annals of Internal Medicine”, 122 (7), 1995, s. 550–552, DOI10.7326/0003-4819-122-7-199504010-00013, PMID7872593 [dostęp 2023-04-18] (ang.).
  • R. Boer i inni, In search of the best upper age limit for breast cancer screening, „European Journal of Cancer”, 31A (12), 1995, s. 2040–2043, DOI10.1016/0959-8049(95)00457-2, PMID8562162 [dostęp 2023-04-18] (ang.).
  • M.E. Costanza, Breast cancer screening in older women. Synopsis of a forum, „Cancer”, 69 (7 Suppl), 1992, s. 1925–1931, DOI10.1002/1097-0142(19920401)69:7+<1925::aid-cncr2820691709>3.0.co;2-u, PMID1544093 [dostęp 2023-04-18] (ang.).
  • K.A. Phillips, G. Glendon, J.A. Knight, Putting the risk of breast cancer in perspective, „The New England Journal of Medicine”, 340 (2), 1999, s. 141–144, DOI10.1056/NEJM199901143400211, PMID9887168 [dostęp 2023-04-18] (ang.).

nytimes.com

onkologia.org.pl

pitt.edu

aei.pitt.edu

web.archive.org

worldcat.org

wp.pl

kobieta.wp.pl